The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus

Clinical Immunology

Volumn 90, Issue 1, 1999, Pages 2-9

  Falcone, Marika ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cytokines; Insulin dependent diabetes mellitus; Transgenic models

Indexed keywords

CANCER GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ANTIGEN PRESENTING CELL; CELL DESTRUCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DIABETOGENESIS; GENE EXPRESSION; HELPER CELL; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

EID: 0032961365     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1998.4619     Document Type: Review

References (104)

1. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:1986;2348-2357.
2. Mosmann T., Coffman R. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
3. Heinzel F. P., Sadick M. D., Holaday B. J., Coffman R. L., Locksley R. M. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 169:1989;59-72.
4. Abbas A. K., Murphy K. M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
5. Cher D. J., Mosmann T. R. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 138:1987;3688-3694.
6. Vassalli P. The pathophysiology of tumor-necrosis factors. Ann. Rev. Immunol. 10:1992;411-452.
7. Coffman R. L., Seymour B. W., Lebman D. A., Hiraki D. D., Christiansen J. A., Shrader B., Cherwinski H. M., Savelkoul H. F., Finkelman F. D., Bond M. W., Mosmann T. R. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102:1988;5-28.
8. Boom W. H., Liano D., Abbas A. K. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin-4 and interleukin-2-producing T cell clones on resting B cells. J. Exp. Med. 167:1988;1350-1363.
9. Brennan F. M., Feldmann M. Cytokines in autoimmunity. Curr. Opin. Immunol. 4:1992;754-759.
10. O'Garra A., Murphy K. T-cell subsets in autoimmunity. Curr. Opin. Immunol. 5:1993;880-886.
11. Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes. 43:1994;613-621.
12. +. Immunol. Today. 16:1995;34-38.
13. +. J. Clin. Invest. 95:1995;2979-2985.
14. Katz J. D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
15. Hancock W. W., Polanski M., Zhang J., Blogg N., Weiner H. L. Suppression of insulitis in non-obese diabetic (NOD) mice by oral administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. Am. J. Pathol. 147:1995;1193-1199.
16. Arreaza G. A. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4 dependent mechanism. J. Clin. Invest. 100:1997;2243-2253.
17. Chen V., Kuchroo V., Inobe J., Hafler D., Weiner H. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
18. Racke M., Bonomo A., Scott D., Cannella B., Levine A., Raine C., Shevach E., Rocken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1966.
19. Falcone M., Bloom B. A T helper cell 2 (Th2) immune response against non-self-antigens modifies the cytokine profile of autoimmune T cells and protects against Experimental Allergic Encephalomyelitis. J. Exp. Med. 185:1997;901-907.
20. Pakala S. V., Kurrer M. O., Katz J. D. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised non-obese diabetic (NOD) mice. J. Exp. Med. 186:1997;299-306.
21. Lafaille J. J., Van de Keere F., Hsu A. L., Baron J. L., Haas W., Raine C. S., Tonegawa S. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:1997;307-312.
22. Sarvetnick N., Liggitt D., Pitts S., Hansen S., Stewart T. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell. 52:1988;773-782.
23. Sarvetnick N., Shizuru J., Liggitt D., Martin L., McIntyre B., Gregory A., Parslow T., Stewart T. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature. 346:1990;844-847.
24. Stewart T. A., Hultgren B., Huang X., Pitts-Meek S., Hully J., MacLachlan N. J. Induction of type 1 diabetes by interferon-α in transgenic mice. Science. 260:1993;1942-1946.
25. Pelegrin M., Devedjian J. C., Costa C., Visa J., Solanes G., Pujol A., Asins G., Valera A., Bosch F. Evidence from transgenic mice that interferon-β may be involved in the onset of diabetes mellitus. J. Biol. Chem. 273:1998.
26. Chakrabarti D., Hultgren B., Stewart T. A. IFN-alfa induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. J. Immunol. 157:1996;522-528.
27. Oldstone M. Overview: Infectious agents as etiologic triggers of autoimmune disease. Curr. Top. Microbiol. Immunol. 145:1989;1-3.
28. Oldstone M. B. A., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response. Cell. 65:1991;319-331.
29. Governman J., Woods A., Larson L., Weiner L., Hood L., Zaller D. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:1993;551-560.
30. Benoist C., Mathis D. The pathogen connection. Nature. 394:1998;227-228.
31. Wucherpfennig K., Strominger J. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
32. Horwitz M., Bradley L., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxackie virus: Initiation by bystander damage and not molecular mimicry. Nat. Med. 4:1998;781-785.
33. Matzinger P. Tolerance, danger, and extended family. Annu. Rev. Immunol. 12:1994;991-1045.
34. Pankewycz O., Strom T. B., Rubin-Kelley V. E. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accellerated onset of diabetes. Eur. J. Immunol. 21:1991;873-879.
35. Kumar V., Stellrecht K., Sercarz E. Inactivation of CD4 regulatory T cells results in chronic autoimmunity. J. Exp. Med. 184:1996;1609-1617.
36. +--. J. Exp. Med. 187:1998;1047-1056.
37. Gu D.-L. A. S. N. Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development. 118:1993;33-46.
38. Gu D., Lee M. S., Krahl T., Sarvetnick N. Transitional cells in the regenerating pancreas. Development. 120:1994;1873-1881.
39. Sarvetnick N., Gu D. Pancreatic Islet Cell Regeneration and Growth. 1992;Plenum, New York.
40. Dubois P. M. Ontogeny of the endocrine pancreas. Horm. Res. 32:1989;53-60.
41. Ruddle N. H., Bergman C. M., McGrath K. M., Lingenheld E. G., Grunnet M. L., Padula S. J., Clark R. B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
42. Jacob C. O. Tumor-necrosis factor-alfa in autoimmunity: Pretty girl or old witch? Immunol. Today. 13:1992;122-125.
43. Ruddle N. H., Picarella D., Kratz A., Li C.-B., Flavell R. A. Probing the mechanism of TNF-α (cachectin)-and TNF-β (lymphotoxin)-induced pancreatic inflammation with transgenic mice. 51st Forum In Immunology TNF in Pathology: Old Facts and New Questions. 144:1993;336-342.
44. Ohashi P. S., Oehen S., Aichele P., Pircher H., Odermatt B., Herrera P., Higuchi Y., Buerki K., Hengartner H., Zingernagel R. M. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alfa. J. Immunol. 150:1993;5185-5194.
45. Hunger R. E., Carnaud C., Garcia I., Vassalli P., Mueller C. Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur. J. Immunol. 27:1997;255-261.
46. Mysliwska J., Zorena K., Bakowska A., Skuratowicz-Kubica A., Mysliwski A. Significance of tumor necrosis factor alpha in patients with long-standing type-I diabetes mellitus. Horm. Metab. Res. 30:1998;158-161.
47. Riminton D. S., Korner H., Strickland D. H., Lemckert F. A., Pollard J. D., Sedgwick J. D. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J. Exp. Med. 187:1998;1517-1528.
48. Yang X.-D., Tisch R., Singer S. M., Cao Z. A., Liblau R. S., Schreiber R. D., McDevitt H. O. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:1994;995-1004.
49. Higuchi Y. H. P., Muniesa P., Huarte J., Belin D., Ohashi P., Aichele P., Orci L., Vassalli J.-D., Vassalli P. Expression of a tumor necrosis factor α transgene in murine pancreatic β cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1992;1719-1731.
50. Grewal I., Grewal K., Wong F., Picarella D., Janeway C. Jr., Flavell R. Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184:1996;1963-1974.
51. Mc Sorley S. J., Soldera S., Malherbe L., Carnaud C., Locksley R., Flavell R. A. Immunological tolerance to a pancreatic antigen as a result of local expression of TNF-alfa by islet beta cells. Immunity. 7:1997;401-409.
52. Guerder S., Picarella D. E., Linsley P. S., Flavell R. A. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor a leads to autoimmunity in transgenic mice. PNAS. 91:1994;5138-5142.
53. LeGros G., Ben-Sasson S. Z., Seder R., Finkelman F. D., Paul W. E. Generation of interleukin-4 (IL-4) producing cells in vivo and in vitro: IL-2 and IL-4 required for in vitro generation of IL-4 producing cells. J. Exp. Med. 172:1990;921-929.
54. +. J. Exp. Med. 176:1992;1091-1098.
55. Rocken M., Urban J., Shevach E. M. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo. J. Exp. Med. 179:1994;1885-1893.
56. Fiorentino D. F., Bond M. W., Mosmann T. R. Two types of mouse T helper cell IV: Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:1989;2081-2095.
57. +. J. Exp. Med. 182:1995;1505-1515.
58. Cameron M., Arreaza G., Zucker P., Chensue S. W., Strieter R. M., Chakrabarti S., Delovitch T. L. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T-helper-2 cell function. J. Immunol. 159:1997;4686-4692.
59. Tominaga Y., Nagata M., Yasuda H., Okamoto N., Arisawa K., Moriyama H., Miki M., Yokono K., Kasuga M. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin. Immunol. Immunopathol. 86:1998;209-218.
60. Mueller R., Krahl T., Sarvetnick N. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1996;1093-1099.
61. Kullberg M. C., Pearce E. J., Hieny S. E., Sher A., Berzofsky J. A. Infection with Schistosoma mansoni alters Th1/Th2 cytokine responses to a non-parasite antigen. J. Immunol. 148:1992;3264-3270.
62. Curry A. J., Else K. J., Jones F., Bancroft A., Grencis R. K., Dunne D. W. Evidence that cytokine-mediated immune interactions induced bySchistosoma mansoniTrichuris muris. J. Exp. Med. 181:1995;769-774.
63. Mueller R., Bradley L. M., Krahl T., Sarvetnick N. Mechanism underlying counter-regulation of autoimmune diabetes by IL-4. Immunity. 7:1997;411-418.
64. Katz J. D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell. 74:1993;1089-1100.
65. Stein M., Keshaw S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunological macrophage activation. J. Exp. Med. 176:1992;287-292.
66. Hart P. H., Bonder C. S., Jones C. A., Finlay-Jones J. J. Control of major histocompatibility complex class II expression on human monocytes by interleukin-4: Regulatory effect of lipopolysaccharide. Immunology. 89:1996;599-605.
67. Kodelja V., Muller C., Politz O., Hakij N., Orfanos C. E., Goerdt S. Alternative macrophage activation-associated CC-Chemokine-1, a novel structural homologue of macrophage inflammatory protein-1alfa with a Th2-associated expression pathway. J. Immunol. 160:1998;1411-1418.
68. Kehrl J. H., Wakefield L. M., Roberts A. B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M. B., Fauci A. S. Production of transforming growth factor b by human T lymphocytes and its potential role in regulating of T cell growth. J. Exp. Med. 163:1986;1037-1050.
69. Kehrl J. H., Thevenin C., Rieckmann P., Fauci A. S. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J. Immunol. 146:1991;4016-4023.
70. +. J. Exp. Med. 180:1994;1937-1942.
71. Bright J. J., Kerr L. D., Sriram S. TGF-beta inhibits IL-2 induced tyrosine phosphorilation and activation of Jak-1 and stat-5 in T lymphocytes. J. Immunol. 159:1997;175-183.
72. Wahl S. M., Hunt D. A., Wong H. L., Dougherty S., McCartney-Francis N., Wahl L. M., Ellingsworth L., Schmidt J. A., Hall G., Roberts A. B., Sporn M. B. Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1 dependent lymphocyte proliferation. J. Immunol. 140:1988;3026-3032.
73. Widder J., Dorfinger K., Wilfing A., Trieb K., Pirich K., Loebenstein R., Niederle B., Gessl A., Spitzauer S., Grubeck-Loebenstein B. The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF-beta inhibits autoreactivity in Graves' disease. J. Autoimmun. 4:1991;689-701.
74. Brandes M. E., Allen J. B., Ogawa Y., Wahl S. M. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87:1991;1108.
75. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted distruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
76. Kulkarni A. B., Huh C. G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M., Karlsson S. Transforming-growth factor beta1 null mutation in mice causes excessive inflammatory response and early death. PNAS. 90:1993;770-774.
77. Christ M., McCartney-Francis N. L., Kulkarni A. B., Ward J. M., Mizel D. E., Mackall C. L., Gress R. E., Hines K. L., Tian H., Karlsson S., Wahl S. M. Immune dysregulation in TGF-beta 1-deficient mice. J. Immunol. 153:1994;1936-1946.
78. Sitnicka E., Ruscetti F. W., Priestley G. V., Wolf N. S., Bartelmez S. H. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 88:1996;82-88.
79. King C., Davies J., Mueller R., Lee M.-S., Krahl T., Yeung B., O'Connor E., Sarvetnick N. TGF-beta 1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity. 8:1998;601-613.
80. Tisch R., Yang X., Singer S., Liblau R., Fugger L., McDevitt H. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
81. Kaufman D. L., Clare-Salzier M., Tian J., Forsthuber T., Ting G. S. P., Robinson P., Atkinson M. A., Sercarz E. E., Tobin A. J., Lehmann P. V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxilase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
82. Tian J. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1996;1348-1353.
83. Zechel M. A., Chaturvedi P., Singh B. Characterization of immunodominant peptide determinants of IDDM-associated autoantigens in the NOD mouse. Res. Immunol. 148:1997;338-348.
84. Falcone M., Lee J., Patstone G., Yeung B., Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161:1998;1163-1168.
85. Mamula M. J., Lin R.-H., Janeway C. A., Hardin J. A. Breaking T cell tolerance with foreign and self co-immunogens. J. Immunol. 149:1992;789-795.
86. Lanzavecchia A. Antigen uptake and accumulation in antigen-specific B cells. Immunol. Rev. 99:1987;39-51.
87. Hodgkin P. D., Basten A. B cell activation, tolerance and antigen-presenting function. Curr. Opin. Immunol. 7:1995;121-129.
88. Mamula M. J., Janeway C. A. Do B cells drive the diversification of immune responses? Immunol. Today. 14:1993;151-152.
89. Mamula M. J., Fatenejad S., Craft S. J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152:1994;1453-1461.
90. Serreze D. V., Chapman H. D., Varnum D. S., Hanson M. S., Reifsnyder P. C., Richard S. D., Fleming S. A., Leiter E. H., Shultz L. D. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new "speed congenic" stock of NOD.Igm null mice. J. Exp. Med. 184:1996;2049-2053.
91. Noorchashm H., Noorchashm N., Kern J., Rostami S. Y., Barker C. F., Naji A. B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes. 46:1997;941-946.
92. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A. O. IL10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
93. Mosmann T. R., Moore K. W. The role of IL-10 in crossregulating of Th1 and Th2 responses. Immunol. Today. 12:1991;49-53.
94. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:1991;3444-3451.
95. Wogensen L., Lee M.-S., Sarvetnick N. Production of interleukin-10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179:1994;1379-1384.
96. Moritani M., Yoshimoto K., Tashiro F., Hashimoto C., Miyazaki J., Ii S., Kudo E., Iwahana H., Hayashi Y., Sano T., Itakura M. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immun. 6:1994;1927-1936.
97. Lee M. S., Wicker L. S., Peterson L. B., Sarvetnick N. Pancreatic IL-10 induces diabetes in NOD. Autoimmunity. 26:1997;215-221.
98. Lee M.-S., Mueller R., Wicker L. S., Peterson L. B., Sarvetnick N. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:1996;2663-2668.
99. Go N. F., Castle B. E., Barrett R., Kastelein R., Dang W., Mosmann T., Moore K. W., Howard M. Interleukin-10 (IL-10), a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficient B cells. J. Exp. Med. 172:1990;1625-1631.
100. Ding L., Shevach E. M. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J. Immunol. 148:1992;3133-3139.
101. Flores Villanueva P. O., Reiser H., Stadecker M. J. Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. J. Immunol. 53:1994;5190-5199.
102. +, J. Immunol.
103. Pennline K., Roque-Gaffney E., Monahan M. Recombinant human IL-10 (rhuIL-10) prevents the onset of diabetes in the nonobese diabetic (NOD) mouse. Clin. Immunol. Immunopathol. 71:1994;169-175.
104. Zheng X. X., Steele A. W., Hancock W. W., Stevens A. C., Nickerson P. W., Roy-Chaudhury P., Tian Y., Strom T. B. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol. 158:1997;4507-4513.